SLRN insider transaction filings
ACELYRIN, Inc. — 45 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-05-23. Screen SLRN transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for SLRN between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — ACELYRIN, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-23 | 4 | Mpofu Shephard — Chief Medical Officer | Disposition to issuer (D): 121,789 · Disposition to issuer (D): 328,860 (derivative) · Disposition to issuer (D): 142,586 (derivative) · Disposition to issuer (D): 118,858 (derivative) | EDGAR |
| 2025-05-23 | 4 | Murugan Amar — Chief Legal Officer | Disposition to issuer (D): 121,587 · Disposition to issuer (D): 525,000 (derivative) | EDGAR |
| 2025-05-23 | 4 | Becker Daniel J. — Director | Disposition to issuer (D): 2,999 · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 92,158 (derivative) | EDGAR |
| 2025-05-23 | 4 | Kim Mina — Chief Executive Officer, Director | Grant/award (A): 89,526 · Disposition to issuer (D): 770,833 · Disposition to issuer (D): 1,195,856 (derivative) · Disposition to issuer (D): 190,114 (derivative) · Disposition to issuer (D): 85,226 (derivative) · Disposition to issuer (D): 362,719 (derivative) | EDGAR |
| 2025-05-23 | 4 | Gosebruch Henry O — Director | Disposition to issuer (D): 50,000 · Disposition to issuer (D): 92,158 (derivative) · Disposition to issuer (D): 155,450 (derivative) | EDGAR |
| 2025-05-23 | 4 | TETRAULT LYNN A. — Director | Disposition to issuer (D): 43,680 (derivative) · Disposition to issuer (D): 89,955 (derivative) | EDGAR |
| 2025-05-23 | 4 | Svoronos Dawn — Director | Disposition to issuer (D): 15,000 · Disposition to issuer (D): 92,158 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 155,450 (derivative) | EDGAR |
| 2025-05-23 | 4 | AyurMaya Capital Management Company, LP — Director, 10% owner GOEL DAVID E. — Director, 10% owner | Disposition to issuer (D): 9,334,735 @ $0 | EDGAR |
| 2025-05-23 | 4 | Machado Patrick — Director | Disposition to issuer (D): 14,675 · Disposition to issuer (D): 92,158 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 28,675 (derivative) · Disposition to issuer (D): 86,206 (derivative) · Disposition to issuer (D): 40,567 (derivative) | EDGAR |
| 2025-05-23 | 4 | COZADD BRUCE C — Director | Disposition to issuer (D): 183,434 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 92,158 (derivative) | EDGAR |
| 2025-05-23 | 4 | SEIDENBERG BETH C — Director | Disposition to issuer (D): 60,000 · Disposition to issuer (D): 9,790,729 · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 92,158 (derivative) | EDGAR |
| 2025-05-19 | 4 | Kim Mina — Chief Executive Officer, Director | Grant/award (A): 30,851 @ $0 · Tax withholding (F): 11,039 @ $2.17 · Tax withholding (F): 10,258 @ $2.17 | EDGAR |
| 2025-03-19 | 4 | Mpofu Shephard — Chief Medical Officer | Sale (S): 3,211 @ $2.74 | EDGAR |
| 2025-03-19 | 4 | Murugan Amar — Chief Legal Officer | Sale (S): 3,913 @ $2.74 | EDGAR |
| 2025-03-19 | 4 | Kim Mina — Chief Executive Officer, Director | Sale (S): 17,986 @ $2.74 | EDGAR |
| 2025-01-24 | 4 | Mpofu Shephard — Chief Medical Officer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-01-24 | 4 | Murugan Amar — Chief Legal Officer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-01-24 | 4 | Kim Mina — Chief Executive Officer, Director | Grant/award (A): 575,000 @ $0 | EDGAR |
| 2024-11-27 | 4 | Murugan Amar — Chief Legal Officer | Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Labrucherie Gil M — CFO and CBO | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | Becker Daniel J. — Director | Sale (S): 1 @ $6.86 | EDGAR |
| 2024-06-11 | 4 | Becker Daniel J. — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Gosebruch Henry O — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | TETRAULT LYNN A. — Director | Grant/award (A): 43,680 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Svoronos Dawn — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Machado Patrick — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | COZADD BRUCE C — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | SEIDENBERG BETH C — Director | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Kim Mina — Chief Executive Officer, Director | Grant/award (A): 1,195,856 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Pangali Sanam — CLO & Head of People | Grant/award (A): 328,860 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Mpofu Shephard — Chief Medical Officer | Grant/award (A): 328,860 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Gloria Melanie — Chief Operating Officer | Grant/award (A): 184,042 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Labrucherie Gil M — CFO and CBO | Grant/award (A): 184,042 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Gloria Melanie — Chief Operating Officer | Tax withholding (F): 10,298 @ $4.47 | EDGAR |
| 2024-05-17 | 4 | Pangali Sanam — CLO & Head of People | Tax withholding (F): 921 @ $4.47 | EDGAR |
| 2024-05-17 | 4 | Kim Mina — Chief Executive Officer, Director | Tax withholding (F): 10,230 @ $4.47 | EDGAR |
| 2024-04-03 | 4 | Lin Shao-Lee — Chief Executive Officer, Director | Sale (S): 9,961 @ $6.63 | EDGAR |
| 2024-02-22 | 4 | Lin Shao-Lee — Chief Executive Officer, Director | Sale (S): 15,701 @ $7.60 | EDGAR |
| 2024-01-11 | 4 | Oyston Ronald — Chief People Officer | Grant/award (A): 123,574 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Gloria Melanie — Chief Operating Officer | Grant/award (A): 494,297 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Lin Shao-Lee — Chief Executive Officer, Director | Grant/award (A): 964,829 (derivative) @ $0 · Grant/award (A): 413,498 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Kim Mina — Chief Legal & Admin. Officer | Grant/award (A): 190,114 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Labrucherie Gil M — Chief Financial Officer | Grant/award (A): 855,513 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Lin Shao-Lee — Chief Executive Officer, Director | Sale (S): 10,691 @ $7.41 | EDGAR |
| 2023-12-20 | 4 | TETRAULT LYNN A. — Director | Grant/award (A): 89,955 (derivative) @ $0 | EDGAR |
Recent 8-K events — ACELYRIN, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-05-21 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-04-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-31 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-01-06 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-12-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-13 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SLRN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →